Related Experiment Video
Updated: Dec 6, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.9K
Cholesterol-modifying drugs in COVID-19.
Nathalie M Schmidt1, Peter A C Wing2, Jane A McKeating2
1Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK.
Oxford Open Immunology
|October 13, 2020
Summary
Cholesterol-modifying drugs may impact severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection outcomes. Research explores how these drugs influence virus-host interactions, potentially offering new therapeutic strategies for COVID-19 management.
Area of Science:
- Biochemistry
- Virology
- Immunology
Background:
- Elderly individuals and those with cardiovascular disease, obesity, or metabolic syndrome face higher risks of poor outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
- Cholesterol plays a critical role in the life cycle of enveloped viruses, including SARS-CoV-2, affecting viral assembly, replication, and infectivity.
Purpose of the Study:
- To investigate the mechanisms by which dyslipidemia and cholesterol-modifying drugs influence the SARS-CoV-2 host relationship.
- To identify cholesterol-modifying drugs that could be tested for their potential to alter the SARS-CoV-2 life cycle.
Main Methods:
- Review of existing literature on cholesterol's role in viral infections and the effects of cholesterol-modifying drugs.
- Analysis of how statins and other cholesterol-modifying agents impact viral infectivity, immunity, and inflammation.
Main Results:
- Cholesterol is vital for enveloped virus particle formation and infectivity.
- Excess cholesterol can impair immune responses and promote excessive inflammation.
- Statins exhibit pleiotropic effects, influencing virus infectivity, immunity, and inflammation in a context-dependent manner.
Conclusions:
- Cholesterol-modifying drugs possess antiviral, immunomodulatory, and anti-inflammatory properties.
- These drugs warrant further investigation for their potential therapeutic applications in managing SARS-CoV-2 infection.
- Targeting cholesterol metabolism presents a potential strategy for improving COVID-19 patient outcomes.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
01:29Cholesterol: Significance and Regulation
1.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.1K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:26Atherosclerosis III: Management
219
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
219
01:26COPD: Management Using Bronchodilators and Corticosteroids
596
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
596